Explore ›
Finding
Finding
adverse
Anticholinergic therapy caused significantly more dry mouth than onabotulinumtoxinA (46% vs 31%, P=0.02), though dry mouth was not a major cause of drug withdrawal.
| Effect size | 46% vs 31% |
| Comparator | OnabotulinumtoxinA 100 U single intradetrusor injection |
| Effect summary | adverse; 46% vs 31% |
| Adverse events | dry mouth 46%, 31% |
Connected entities
Interventions
Conditions
Outcomes
Source
PMC3543828
Anticholinergic Therapy vs. OnabotulinumtoxinA for Urgency Urinary Incontinence